Bengaluru, India

Pavan Kumar Gondrala


 

 

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovator Pavan Kumar Gondrala: Advancements in Cancer Treatment**

Introduction

Pavan Kumar Gondrala is a notable inventor based in Bengaluru, India. With a total of four patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in the area of cancer treatment. His work reflects a strong commitment to innovation and improving healthcare outcomes.

Latest Patents

Gondrala's recent patents showcase his expertise in developing novel compounds that offer promising therapeutic applications. His latest inventions include:

1. **Tricyclic Fused Derivatives of 1-(Cyclo)alkyl Pyridin-2-One**: This patent describes heterocyclic compounds with high anticancer activity. The compounds, along with their stereoisomers and pharmaceutically active derivatives, have the potential to be used as medicaments for the treatment and prevention of diseases mediated by the BET family of bromodomains.

2. **Tricyclic Fused Pyridin-2-One Derivatives as BRD4 Inhibitors**: Similar to his previous invention, this patent also addresses heterocyclic compounds that exhibit significant anticancer properties. It includes details on the synthesis and characterization of the compounds intended for medicinal use against diseases linked to BET family of bromodomains.

Career Highlights

Pavan Kumar Gondrala is actively engaged with Jubilant Biosys Limited, where he has honed his skills and made impactful contributions. His innovative approach and dedication to research have established him as a key figure in the pharmaceutical sector.

Collaborations

Throughout his career, Gondrala has collaborated with talented coworkers like Saravanan Vadivelu and Sridharan Rajagopal. These partnerships enhance collective research efforts, driving forward the discovery and refinement of new therapeutic agents.

Conclusion

Pavan Kumar Gondrala exemplifies the spirit of innovation in the field of pharmaceuticals. His contributions, particularly through his recent patents, hold a promise for advancing cancer treatment options. As research continues to evolve, his work stands as a testament to the impactful role of inventors in healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…